Literature DB >> 33740242

Overview: Lipid Metabolism in the Tumor Microenvironment.

Kaili Ma1,2, Lianjun Zhang3,4.   

Abstract

The tumor microenvironment represents the dynamic network consisting of tumor cells, stromal cells, and multiple lineages of immune subsets. It is well recognized that metabolic crosstalk within the tumor microenvironment (TME) greatly shapes both the composition and functionality of the infiltrated immune cells and therefore critically regulate the antitumor immunity. In general, most solid tumors are considered as lipid-enriched environment, which is beneficial for tumor cell growth and immune escape. Here we briefly summarize the effects of accumulated lipids on tumor cells and immune cells. We also discuss the possibility of targeting lipid metabolism within the TME and potential strategies for optimizing cancer treatment.

Entities:  

Keywords:  Antitumor immunity; Immunosuppression; Lipid metabolism; T cells; Tumor microenvironment

Mesh:

Year:  2021        PMID: 33740242     DOI: 10.1007/978-981-33-6785-2_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  58 in total

Review 1.  Metabolic Interactions in the Tumor Microenvironment.

Authors:  Costas A Lyssiotis; Alec C Kimmelman
Journal:  Trends Cell Biol       Date:  2017-07-19       Impact factor: 20.808

Review 2.  Tumors as organs: complex tissues that interface with the entire organism.

Authors:  Mikala Egeblad; Elizabeth S Nakasone; Zena Werb
Journal:  Dev Cell       Date:  2010-06-15       Impact factor: 12.270

3.  Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment.

Authors:  Xingzhe Ma; Enguang Bi; Yong Lu; Pan Su; Chunjian Huang; Lintao Liu; Qiang Wang; Maojie Yang; Matthew F Kalady; Jianfei Qian; Aijun Zhang; Anisha A Gupte; Dale J Hamilton; Chengyun Zheng; Qing Yi
Journal:  Cell Metab       Date:  2019-04-25       Impact factor: 27.287

Review 4.  Understanding the tumor immune microenvironment (TIME) for effective therapy.

Authors:  Mikhail Binnewies; Edward W Roberts; Kelly Kersten; Vincent Chan; Douglas F Fearon; Miriam Merad; Lisa M Coussens; Dmitry I Gabrilovich; Suzanne Ostrand-Rosenberg; Catherine C Hedrick; Robert H Vonderheide; Mikael J Pittet; Rakesh K Jain; Weiping Zou; T Kevin Howcroft; Elisa C Woodhouse; Robert A Weinberg; Matthew F Krummel
Journal:  Nat Med       Date:  2018-04-23       Impact factor: 53.440

Review 5.  Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.

Authors:  Kristin G Anderson; Ingunn M Stromnes; Philip D Greenberg
Journal:  Cancer Cell       Date:  2017-03-13       Impact factor: 31.743

Review 6.  Metabolism shapes the tumor microenvironment.

Authors:  Miguel Reina-Campos; Jorge Moscat; Maria Diaz-Meco
Journal:  Curr Opin Cell Biol       Date:  2017-06-09       Impact factor: 8.382

Review 7.  Phosphatidylinositol 3-phosphates-at the interface between cell signalling and membrane traffic.

Authors:  Andrea L Marat; Volker Haucke
Journal:  EMBO J       Date:  2016-02-17       Impact factor: 11.598

Review 8.  Sphingosine 1-phosphate: Lipid signaling in pathology and therapy.

Authors:  Andreane Cartier; Timothy Hla
Journal:  Science       Date:  2019-10-18       Impact factor: 47.728

9.  Prostaglandin signaling regulates renal multiciliated cell specification and maturation.

Authors:  Amanda N Marra; Basma D Adeeb; Brooke E Chambers; Bridgette E Drummond; Marisa Ulrich; Amanda Addiego; Meghan Springer; Shahram J Poureetezadi; Joseph M Chambers; Matthew Ronshaugen; Rebecca A Wingert
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-04       Impact factor: 11.205

Review 10.  DAG tales: the multiple faces of diacylglycerol--stereochemistry, metabolism, and signaling.

Authors:  Thomas Oliver Eichmann; Achim Lass
Journal:  Cell Mol Life Sci       Date:  2015-07-08       Impact factor: 9.261

View more
  5 in total

1.  Lipid metabolism-related gene prognostic index (LMRGPI) reveals distinct prognosis and treatment patterns for patients with early-stage pulmonary adenocarcinoma.

Authors:  Aimin Jiang; Xue Chen; Haoran Zheng; Na Liu; Qianqian Ding; Yimeng Li; Chaoxin Fan; Xiao Fu; Xuan Liang; Tao Tian; Zhiping Ruan; Yu Yao
Journal:  Int J Med Sci       Date:  2022-03-28       Impact factor: 3.642

2.  Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.

Authors:  Aimin Jiang; Jingjing Wang; Na Liu; Xiaoqiang Zheng; Yimeng Li; Yuyan Ma; Haoran Zheng; Xue Chen; Chaoxin Fan; Rui Zhang; Xiao Fu; Yu Yao
Journal:  Front Genet       Date:  2022-01-27       Impact factor: 4.599

3.  lncRNA ZFAS1 Promotes HMGCR mRNA Stabilization via Binding U2AF2 to Modulate Pancreatic Carcinoma Lipometabolism.

Authors:  Luoluo Wang; Yi Ruan; Xiang Wu; Xinhua Zhou
Journal:  J Immunol Res       Date:  2022-07-08       Impact factor: 4.493

4.  Exploration of hub genes, lipid metabolism, and the immune microenvironment in stomach carcinoma and cholangiocarcinoma.

Authors:  Yuda Gong; Xuan Liu; Arvind Sahu; Abhinav V Reddy; Haiyu Wang
Journal:  Ann Transl Med       Date:  2022-08

5.  Development and validation of a screening model for lung cancer using machine learning: A large-scale, multi-center study of biomarkers in breath.

Authors:  Jing Li; Yuwei Zhang; Qing Chen; Zhenhua Pan; Jun Chen; Meixiu Sun; Junfeng Wang; Yingxin Li; Qing Ye
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.